Heme and solid tumor targeing and selective tumor killing​

In vivo CAR and targeted payload delivery​

Novel therapeutic approaches to hard-to-drugestablished targets in oncogenic driver signaling​

In vivo CAR and targeted payload delivery​

Tolerance induction​

Tissue homeostasis​

Th2 biology (also in combination with standard ofcare)​

Respiratory biology (e.g., asthma)​

Regenerative medicine​

Targeted fat reduction​

Hair growth​

Body contouring and muscle preservation/growth​

Therapeutic neurotoxin engineering​

Psychiatry​

Migraine and Neuropathic Pain​

Movement disorders​

New targets, biomarkers and blood brain barrier-penetrating technologies for cell and tissue selectivepayload delivery​

Large and small molecules​

Peptides and macrocycles​

Genetic medicine (payload and delivery technologies)​

Cell or tissue specific protein/RNA degraders​

Molecular glues​

Antibody drug conjugates (linkers and novel payloads)​

RNA therapeutics​

T-cell engagers​

Obesity, including improved convenience, tolerability, and bodycomposition​

GI/hepatology (e.g., MASH)​

Devices, Diagnostics, Research Tools, HealthcareServices/IT, Cell therapy (auto/allo)